Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015:2015:840542.
doi: 10.1155/2015/840542. Epub 2015 Dec 16.

Novel Investigations of Flavonoids as Chemopreventive Agents for Hepatocellular Carcinoma

Affiliations
Review

Novel Investigations of Flavonoids as Chemopreventive Agents for Hepatocellular Carcinoma

Chen-Yi Liao et al. Biomed Res Int. 2015.

Abstract

We would like to highlight the application of natural products to hepatocellular carcinoma (HCC). We will focus on the natural products known as flavonoids, which target this disease at different stages of hepatocarcinogenesis. In spite of the use of chemotherapy and radiotherapy in treating HCC, patients with HCC still face poor prognosis because of the nature of multidrug resistance and toxicity derived from chemotherapy and radiotherapy. Flavonoids can be found in many vegetables, fruits, and herbal medicines that exert their different anticancer effects via different intracellular signaling pathways and serve as antioxidants. In this review, we will discuss seven common flavonoids that exert different biological effects against HCC via different pathways.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Chemical structures of flavonoids that target HCC: EGCG (a), galangin (b), quercetin (c), baicalein (d), oroxylin A (e), genistein (f), and silibinin (g). EGCG: (−)-epigallocatechin-3-gallate; HCC: hepatocellular carcinoma.
Figure 2
Figure 2
QUORUM algorithm of review of the flavonoids and hepatocellular carcinoma publications and abstracts.
Figure 3
Figure 3
The different stages of HCC and the major targets modulated by various flavonoids. HCC: hepatocellular carcinoma; EGCG: (−)-epigallocatechin-3-gallate.

Similar articles

Cited by

References

    1. Burak K. W., Sherman M. Hepatocellular carcinoma: consensus, controversies and future directions. A report from the Canadian Association for the Study of the Liver Hepatocellular Carcinoma Meeting. Canadian Journal of Gastroenterology & Hepatology. 2015;29(4):178–184. - PMC - PubMed
    1. Schlachterman A., Craft W. W., Jr., Hilgenfeldt E., Mitra A., Cabrera R. Current and future treatments for hepatocellular carcinoma. World Journal of Gastroenterology. 2015;21(28):8478–8491. doi: 10.3748/wjg.v21.i28.8478. - DOI - PMC - PubMed
    1. Parkin D. M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA: A Cancer Journal for Clinicians. 2005;55(2):74–108. doi: 10.3322/canjclin.55.2.74. - DOI - PubMed
    1. Srivatanakul P., Sriplung H., Deerasamee S. Epidemiology of liver cancer: an overview. Asian Pacific Journal of Cancer Prevention. 2004;5(2):118–125. - PubMed
    1. Bosch F. X., Ribes J., Díaz M., Ribes J. Primary liver cancer: worldwide incidence and trends. Gastroenterology. 2004;127(5, supplement 1):S5–S16. - PubMed

MeSH terms

LinkOut - more resources